Tag: biosimilar

May 3, 2018

New to the Investing News Network

Here at the Investing News Network our mission is twofold; to provide the latest news and quality education by helping...
March 1, 2018

Biocure appoints Lichtenwald CFO, director

Biocure Technology Inc. (formerly Gravis Energy Corp.) (CSE: CURE) (the"Company" or "Biocure") is pleased to announce that effective of today's...
February 21, 2018

Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update

Momenta Pharmaceuticals (Nasdaq:MNTA) today reported its financial results for the fourth quarter and year ended December 31, 2017 and provided a...
February 20, 2018

BioCure Announces a Contract with Osong Hi-Tech Medical Industry Promotion Foundation

Biocure Technology Inc. (CSE: CURE) (formerly Gravis Energy Corp.) (the “Company” or “Biocure”) announces that on February 19, 2018, has...
February 15, 2018

Agios Receives FDA Priority Review for New Drug Application: How are Gene Therapy Drug Approvals Impacting Stocks?

INN is taking a look at what other companies have received FDA approval for gene therapy drugs and how the...
February 14, 2018

Oncobiologics Reports First Quarter Fiscal Year 2018 Results

Oncobiologics (NASDAQ:ONS) today reported financial results and business highlights for its first fiscal quarter ended December 31, 2017. Oncobiologics had...
January 31, 2018

BioCure Unaware of Any Material Change

Biocure Technology Inc. (formerly Gravis Energy Corp.) (CSE: CURE) (the "Company" or "Biocure) At the request of IIROC, Biocure wishes...